Do analysts prefer GRML or ADCT?

ADC Therapeutics has a consensus price target of $6.25, indicating a potential upside of 492.42%. Given ADC Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe ADC Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 ADC Therapeutics 1 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.33

Does the media prefer GRML or ADCT?

In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 2 articles in the media. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 beat ADC Therapeutics' score of -0.67 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ADC Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts rate GRML or CNTX?

Context Therapeutics has a consensus price target of $6.60, indicating a potential upside of 634.15%. Given Context Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Context Therapeutics is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Context Therapeutics 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 2.88

Which has preferable earnings and valuation, GRML or CNTX?

Context Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Greenland Mines Ltd. Common Stock N/A N/A -$10.55M -$0.32 N/A Context Therapeutics N/A N/A -$36.12M -$0.42 N/A

Is GRML or CNTX more profitable?

Context Therapeutics' return on equity of -59.95% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Context Therapeutics N/A -59.95% -54.78%

Does the media favor GRML or CNTX?

In the previous week, Context Therapeutics had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Context Therapeutics and 2 mentions for Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 equaled Context Therapeutics'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Context Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NRXP or GRML?

NRx Pharmaceuticals presently has a consensus price target of $38.25, indicating a potential upside of 861.06%. Given NRx Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe NRx Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NRx Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50 Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NRXP or GRML more profitable?

NRx Pharmaceuticals' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets NRx Pharmaceuticals N/A N/A -202.92% Greenland Mines Ltd. Common Stock N/A -109.40% -98.80%

Does the media refer more to NRXP or GRML?

In the previous week, NRx Pharmaceuticals and NRx Pharmaceuticals both had 2 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.20 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that NRx Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment NRx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is SPRB or GRML more profitable?

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Spruce Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Spruce Biosciences N/A -155.40% -101.67% Greenland Mines Ltd. Common Stock N/A -109.40% -98.80%

Does the media refer more to SPRB or GRML?

In the previous week, Spruce Biosciences had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Spruce Biosciences and 2 mentions for Greenland Mines Ltd. Common Stock. Spruce Biosciences' average media sentiment score of 0.96 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Spruce Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spruce Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Greenland Mines Ltd. Common Stock 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend GRML or CNTB?

Connect Biopharma has a consensus price target of $7.20, indicating a potential upside of 227.87%. Given Connect Biopharma's stronger consensus rating and higher probable upside, analysts plainly believe Connect Biopharma is more favorable than Greenland Mines Ltd. Common Stock. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Greenland Mines Ltd. Common Stock 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Connect Biopharma 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86

Is GRML or CNTB more profitable?

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Connect Biopharma's return on equity. Company Net Margins Return on Equity Return on Assets Greenland Mines Ltd. Common Stock N/A -109.40% -98.80% Connect Biopharma N/A -122.29% -97.07%

Greenland Mines Ltd. Common Stock (GRML) Competitors

$0.30 +0.00 (+1.67%)

As of 09:45 AM Eastern

Compare

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

Should you buy Greenland Mines Ltd. Common Stock stock or one of its competitors? MarketBeat compares Greenland Mines Ltd. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Greenland Mines Ltd. Common Stock include ADC Therapeutics (ADCT), Context Therapeutics (CNTX), NRx Pharmaceuticals (NRXP), Spruce Biosciences (SPRB), and Connect Biopharma (CNTB). These companies are all part of the "pharmaceutical products" industry.

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and ADC Therapeutics (NYSE:ADCT) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than ADC Therapeutics. ADC Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
ADC Therapeutics	$81.36M	1.65	-$142.62M	-$1.05	N/A

20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 41.1% of ADC Therapeutics shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by insiders. Comparatively, 5.4% of ADC Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Greenland Mines Ltd. Common Stock has a beta of 6.94, suggesting that its share price is 594% more volatile than the broader market. Comparatively, ADC Therapeutics has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market.

In the previous week, Greenland Mines Ltd. Common Stock and Greenland Mines Ltd. Common Stock both had 2 articles in the media. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 beat ADC Therapeutics' score of -0.67 indicating that Greenland Mines Ltd. Common Stock is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ADC Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

ADC Therapeutics has a consensus price target of $6.25, indicating a potential upside of 492.42%. Given ADC Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe ADC Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
ADC Therapeutics	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Greenland Mines Ltd. Common Stock has a net margin of 0.00% compared to ADC Therapeutics' net margin of -173.02%. ADC Therapeutics' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
ADC Therapeutics	-173.02%	N/A	-44.70%

Summary

Greenland Mines Ltd. Common Stock and ADC Therapeutics tied by winning 7 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Context Therapeutics (NASDAQ:CNTX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, profitability, valuation, earnings, media sentiment and analyst recommendations.

In the previous week, Context Therapeutics had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Context Therapeutics and 2 mentions for Greenland Mines Ltd. Common Stock. Greenland Mines Ltd. Common Stock's average media sentiment score of 0.93 equaled Context Therapeutics'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Context Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Context Therapeutics' return on equity of -59.95% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Context Therapeutics	N/A	-59.95%	-54.78%

Context Therapeutics is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Context Therapeutics	N/A	N/A	-$36.12M	-$0.42	N/A

Context Therapeutics has a consensus price target of $6.60, indicating a potential upside of 634.15%. Given Context Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Context Therapeutics is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Context Therapeutics	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.88

Greenland Mines Ltd. Common Stock has a beta of 6.94, meaning that its stock price is 594% more volatile than the broader market. Comparatively, Context Therapeutics has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market.

20.1% of Greenland Mines Ltd. Common Stock shares are owned by institutional investors. Comparatively, 14.0% of Context Therapeutics shares are owned by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are owned by company insiders. Comparatively, 4.8% of Context Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Context Therapeutics beats Greenland Mines Ltd. Common Stock on 7 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

NRx Pharmaceuticals (NASDAQ:NRXP) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

NRx Pharmaceuticals presently has a consensus price target of $38.25, indicating a potential upside of 861.06%. Given NRx Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts clearly believe NRx Pharmaceuticals is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NRx Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, NRx Pharmaceuticals and NRx Pharmaceuticals both had 2 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.20 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that NRx Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
NRx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NRx Pharmaceuticals has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 6.94, meaning that its stock price is 594% more volatile than the broader market.

4.3% of NRx Pharmaceuticals shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 6.4% of NRx Pharmaceuticals shares are held by company insiders. Comparatively, 11.3% of Greenland Mines Ltd. Common Stock shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

NRx Pharmaceuticals' return on equity of 0.00% beat Greenland Mines Ltd. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NRx Pharmaceuticals	N/A	N/A	-202.92%
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%

Greenland Mines Ltd. Common Stock has lower revenue, but higher earnings than NRx Pharmaceuticals. NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NRx Pharmaceuticals	$1.23M	117.23	-$28.62M	-$1.09	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Summary

Greenland Mines Ltd. Common Stock beats NRx Pharmaceuticals on 7 of the 13 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Spruce Biosciences (NASDAQ:SPRB) and Greenland Mines Ltd. Common Stock (NASDAQ:GRML) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Greenland Mines Ltd. Common Stock has lower revenue, but higher earnings than Spruce Biosciences. Spruce Biosciences is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spruce Biosciences	$4.91M	28.50	-$38.97M	-$36.60	N/A
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A

Spruce Biosciences has a beta of 3.12, indicating that its share price is 212% more volatile than the broader market. Comparatively, Greenland Mines Ltd. Common Stock has a beta of 6.94, indicating that its share price is 594% more volatile than the broader market.

91.7% of Spruce Biosciences shares are held by institutional investors. Comparatively, 20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. 4.3% of Spruce Biosciences shares are held by insiders. Comparatively, 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Spruce Biosciences had 1 more articles in the media than Greenland Mines Ltd. Common Stock. MarketBeat recorded 3 mentions for Spruce Biosciences and 2 mentions for Greenland Mines Ltd. Common Stock. Spruce Biosciences' average media sentiment score of 0.96 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Spruce Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spruce Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Greenland Mines Ltd. Common Stock	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Spruce Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spruce Biosciences	N/A	-155.40%	-101.67%
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%

Spruce Biosciences currently has a consensus target price of $169.67, indicating a potential upside of 233.46%. Given Spruce Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Spruce Biosciences is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spruce Biosciences	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Spruce Biosciences and Greenland Mines Ltd. Common Stock tied by winning 7 of the 14 factors compared between the two stocks.

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) and Connect Biopharma (NASDAQ:CNTB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

In the previous week, Greenland Mines Ltd. Common Stock had 1 more articles in the media than Connect Biopharma. MarketBeat recorded 2 mentions for Greenland Mines Ltd. Common Stock and 1 mentions for Connect Biopharma. Connect Biopharma's average media sentiment score of 1.89 beat Greenland Mines Ltd. Common Stock's score of 0.93 indicating that Connect Biopharma is being referred to more favorably in the news media.

Company	Overall Sentiment
Greenland Mines Ltd. Common Stock	Positive
Connect Biopharma	Very Positive

Connect Biopharma has a consensus price target of $7.20, indicating a potential upside of 227.87%. Given Connect Biopharma's stronger consensus rating and higher probable upside, analysts plainly believe Connect Biopharma is more favorable than Greenland Mines Ltd. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Greenland Mines Ltd. Common Stock	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Connect Biopharma	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

Greenland Mines Ltd. Common Stock's return on equity of -109.40% beat Connect Biopharma's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Greenland Mines Ltd. Common Stock	N/A	-109.40%	-98.80%
Connect Biopharma	N/A	-122.29%	-97.07%

Greenland Mines Ltd. Common Stock has higher earnings, but lower revenue than Connect Biopharma. Connect Biopharma is trading at a lower price-to-earnings ratio than Greenland Mines Ltd. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Greenland Mines Ltd. Common Stock	N/A	N/A	-$10.55M	-$0.32	N/A
Connect Biopharma	$60K	2,304.34	-$55.48M	-$1.15	N/A

20.1% of Greenland Mines Ltd. Common Stock shares are held by institutional investors. Comparatively, 58.7% of Connect Biopharma shares are held by institutional investors. 11.3% of Greenland Mines Ltd. Common Stock shares are held by insiders. Comparatively, 22.6% of Connect Biopharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Greenland Mines Ltd. Common Stock has a beta of 6.94, suggesting that its share price is 594% more volatile than the broader market. Comparatively, Connect Biopharma has a beta of -0.22, suggesting that its share price is 122% less volatile than the broader market.

Summary

Connect Biopharma beats Greenland Mines Ltd. Common Stock on 9 of the 15 factors compared between the two stocks.

Get Greenland Mines Ltd. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GRML vs. The Competition

Export

Metric	Greenland Mines Ltd. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$36.12M	$2.99B	$6.49B	$12.31B
Dividend Yield	N/A	1.76%	2.67%	5.66%
P/E Ratio	-0.93	18.81	24.05	24.76
Price / Sales	N/A	468.63	542.61	168.32
Price / Cash	N/A	55.88	27.48	37.92
Price / Book	2.29	4.01	10.69	6.90
Net Income	-$10.55M	$75.79M	$3.57B	$337.45M
7 Day Performance	-3.90%	2.78%	1.56%	2.84%
1 Month Performance	-22.68%	0.52%	2.49%	4.78%
1 Year Performance	-81.38%	24.68%	26.51%	33.08%

Greenland Mines Ltd. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GRML Greenland Mines Ltd. Common Stock	0.4086 of 5 stars	$0.30 +1.7%	N/A	-81.7%	$36.12M	N/A	N/A	5	Gap Up
ADCT ADC Therapeutics	2.3385 of 5 stars	$1.10 -0.5%	$6.25 +470.8%	-70.8%	$141.31M	$81.36M	N/A	310
CNTX Context Therapeutics	3.1597 of 5 stars	$1.49 -2.3%	$6.60 +344.4%	+120.8%	$136.44M	N/A	N/A	7
NRXP NRx Pharmaceuticals	2.9809 of 5 stars	$3.76 -2.8%	$38.25 +916.5%	+11.6%	$136.41M	$1.23M	N/A	2	Positive News Analyst Upgrade
SPRB Spruce Biosciences	2.5943 of 5 stars	$48.50 -1.1%	$169.67 +249.9%	+826.2%	$133.39M	$4.91M	N/A	20	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GRML) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Summary

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Summary

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Greenland Mines Ltd. Common Stock (GRML) Competitors

GRML vs. ADCT, CNTX, NRXP, SPRB, and CNTB

How does Greenland Mines Ltd. Common Stock compare to ADC Therapeutics?

Which has better earnings & valuation, GRML or ADCT?

Do institutionals & insiders believe in GRML or ADCT?

Which has more risk & volatility, GRML or ADCT?

Does the media prefer GRML or ADCT?

Do analysts prefer GRML or ADCT?

Is GRML or ADCT more profitable?

Summary

How does Greenland Mines Ltd. Common Stock compare to Context Therapeutics?

Does the media favor GRML or CNTX?

Is GRML or CNTX more profitable?

Which has preferable earnings and valuation, GRML or CNTX?

Do analysts rate GRML or CNTX?

Which has more risk and volatility, GRML or CNTX?

Do insiders and institutionals believe in GRML or CNTX?

Summary

How does Greenland Mines Ltd. Common Stock compare to NRx Pharmaceuticals?

Do analysts prefer NRXP or GRML?

Does the media refer more to NRXP or GRML?

Which has more volatility and risk, NRXP or GRML?

Do institutionals and insiders believe in NRXP or GRML?

Is NRXP or GRML more profitable?

Which has higher earnings and valuation, NRXP or GRML?

Summary

How does Greenland Mines Ltd. Common Stock compare to Spruce Biosciences?

Which has higher valuation & earnings, SPRB or GRML?

Which has more volatility and risk, SPRB or GRML?

Do institutionals & insiders believe in SPRB or GRML?

Does the media refer more to SPRB or GRML?

Is SPRB or GRML more profitable?

Do analysts recommend SPRB or GRML?

Summary

How does Greenland Mines Ltd. Common Stock compare to Connect Biopharma?

Does the media favor GRML or CNTB?

Do analysts recommend GRML or CNTB?

Is GRML or CNTB more profitable?

Which has higher valuation & earnings, GRML or CNTB?

Do institutionals and insiders hold more shares of GRML or CNTB?

Which has more risk & volatility, GRML or CNTB?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GRML vs. The Competition

Greenland Mines Ltd. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools